Eyelid surgery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. The growth of the market is attributed to factors such as the increasing aesthetic concerns, rising demand for cosmetic procedures, and advancements in surgical techniques. Further, the aging population and growing awareness about the benefits of eyelid surgery are some of the factors anticipated to fuel the demand for Eyelid Surgery. For instance, according to the International Survey on Aesthetic/Cosmetic Procedures 2021, a total of 1,446,890 eyelid surgeries were performed. Out of these procedures, 1,142,957 were conducted on females, and 303,932 on males.

Segmental Outlook

The global eyelid surgery market is segmented based on its procedure type and end user. Based on its procedure type, the market is segmented into upper eyelid surgery and lower eyelid surgery. Based on the end user, the market is categorized into clinics & surgery centers and hospitals. Among the procedure type segment, the upper eyelid surgery sub-segment is anticipated to register a significant growth over the forecast period, owing to the growing desire to improve appearance, correct droopy eyelids, and enhance vision among the global population.

The Clinics & Surgery Centers Sub-Segment is Anticipated to Register Significant Growth For the Forecast Period

Among the end user segment, the clinics & surgery centers sub-segment is anticipated to register a significant growth over the forecast period.  The primary factor supporting the segment’s growth includes the growing number of clinics and skilled cosmetic & plastic surgeons along with the rising preference for Blepharoplasty. Blepharoplasty, also known as an eyelid lift, is in the top five most popular cosmetic surgeries. According to the report published by International Society of Aesthetic Plastic Surgery in 2021, it has been estimated that a total of 149,668 eyelid Surgery procedures were performed in the US whereas 53,253 numbers of eyelid surgery were performed in Mexico in 2021.

Regional Outlooks

The global eyelid surgery market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the European eyelid surgery market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the eyelid surgery market. This can be attributed to the increasing aging population, the rising demand for cosmetic surgery, and gaining popularity of blepharoplasty as a medical treatment. Besides, a growing number of patients undergoing eyelid surgery in economies such as South Korea & Japan and expanding the cosmetic industry in India & China are some factors fuelling the regional market growth. For instance, in 2021, the International Survey on Aesthetic/Cosmetic Procedures 2021, estimated that total 370,656 surgical procedures were performed in India, out of these, 24,480 were eyelid surgeries performed.

Global Eyelid Surgery Market Growth, by Region 2023-2030

The North American Region is anticipated to Hold a Significant Share in the Global Eyelid Surgery Market

Among all the regions, the North America region is anticipated to account for a significant share in the eyelid surgery market during the forecast period. The regional market growth is primarily driven by factors including the presence of huge elderly population, increasing demand for cosmetic procedures, and advancements in surgical technologies.

Most Common Surgery Performed in the US-2021

Source: International Society of Aesthetic Plastic Surgery

According to the International Society of Aesthetic Plastic Surgery, the most common surgeries performed in the US were liposuction, breast augmentation, abdominoplasty, breast lift, and eyelid surgery in 2021. Out of which, eyelid surgery experienced a notable increment of 7.5% compared to past years. There are several potential factors that could have contributed to the increase, including advancements in surgical techniques, an aging population's interest in cosmetic procedures, growing awareness of available options, the influence of social media and celebrity culture, improved economic conditions, medical tourism, and psychological factors such as increased self-confidence and self-awareness.

Market Players Outlook

The major companies serving the global eyelid surgery market include Galderma SA, Cutera Inc., Stanford Health Care, Anika Therapeutics Inc, and AbbVie Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Galderma collaborated with SCOPE Miami Beach 2022, the premier showcase for emerging contemporary art. As the exclusive aesthetic injectables sponsor, Galderma highlighted its aesthetics portfolio and hosted a variety of activations for visitors. This collaboration builds on the momentum of Restylane's "XpresYourself" communications campaign, aimed at destigmatizing aesthetics and promoting natural-looking results.

The Report Covers

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global eyelid surgery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.